Higher rates of venous thromboembolism for Black-Americans are likely due to lower serum 25-hydroxyvitamin D levels

American Journal of Hematology

Volumn 85, Issue 11, 2010, Pages 908-908

  Grant, William B ^a  

^a Sunlight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL;

AFRICAN AMERICAN; EUROPEAN AMERICAN; HERITABILITY; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; RISK REDUCTION; UNITED STATES; VENOUS THROMBOEMBOLISM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AFRICAN AMERICANS; HUMANS; INCIDENCE; UNITED STATES; VENOUS THROMBOEMBOLISM; VITAMIN D;

EID: 77958574648     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21825     Document Type: Letter

References (5)

1. Heit JA, Beckman MG, Bockenstedt PL, et al. Comparison of characteristics from White- and Black-Americans with venous thromboembolism: A cross-sectional study. Am J Hematol 2010; 85: 467-471.
2. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169: 626-632.
3. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 2010; 65: 225-236.
4. Lindqvist PG, Epstein E, Olsson H. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis. J Thromb Haemost 2009; 7: 605-610.
5. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in Black-White health disparities in the United States. J Am Med Direct Assoc, in press.